nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.542	1	CrCtD
Cyclobenzaprine—Naftifine—Tamoxifen—pancreatic cancer	0.049	0.174	CrCrCtD
Cyclobenzaprine—Doxylamine—Tamoxifen—pancreatic cancer	0.034	0.121	CrCrCtD
Cyclobenzaprine—Tripelennamine—Tamoxifen—pancreatic cancer	0.0308	0.109	CrCrCtD
Cyclobenzaprine—Dimetacrine—Tamoxifen—pancreatic cancer	0.0288	0.102	CrCrCtD
Cyclobenzaprine—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.0288	0.102	CrCrCtD
Cyclobenzaprine—Clofedanol—Tamoxifen—pancreatic cancer	0.0233	0.083	CrCrCtD
Cyclobenzaprine—Orphenadrine—Tamoxifen—pancreatic cancer	0.0226	0.0803	CrCrCtD
Cyclobenzaprine—Benzphetamine—Tamoxifen—pancreatic cancer	0.0226	0.0803	CrCrCtD
Cyclobenzaprine—Promazine—Tamoxifen—pancreatic cancer	0.0216	0.0767	CrCrCtD
Cyclobenzaprine—CYP1A2—Dacarbazine—pancreatic cancer	0.0203	0.159	CbGbCtD
Cyclobenzaprine—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0201	0.0713	CrCrCtD
Cyclobenzaprine—CYP1A2—Tamoxifen—pancreatic cancer	0.0162	0.127	CbGbCtD
Cyclobenzaprine—CYP1A2—Erlotinib—pancreatic cancer	0.0137	0.108	CbGbCtD
Cyclobenzaprine—CYP2D6—Tamoxifen—pancreatic cancer	0.0133	0.104	CbGbCtD
Cyclobenzaprine—CYP1A2—Fluorouracil—pancreatic cancer	0.0119	0.0934	CbGbCtD
Cyclobenzaprine—CYP2D6—Erlotinib—pancreatic cancer	0.0113	0.0888	CbGbCtD
Cyclobenzaprine—CYP3A4—Tamoxifen—pancreatic cancer	0.00847	0.0664	CbGbCtD
Cyclobenzaprine—CYP3A4—Erlotinib—pancreatic cancer	0.0072	0.0564	CbGbCtD
Cyclobenzaprine—CYP3A4—Irinotecan—pancreatic cancer	0.0065	0.051	CbGbCtD
Cyclobenzaprine—CYP2D6—Doxorubicin—pancreatic cancer	0.00559	0.0438	CbGbCtD
Cyclobenzaprine—CYP3A4—Docetaxel—pancreatic cancer	0.00477	0.0373	CbGbCtD
Cyclobenzaprine—CYP3A4—Sunitinib—pancreatic cancer	0.00474	0.0372	CbGbCtD
Cyclobenzaprine—CYP3A4—Doxorubicin—pancreatic cancer	0.00355	0.0278	CbGbCtD
Cyclobenzaprine—Rash—Erlotinib—pancreatic cancer	8.17e-05	0.00167	CcSEcCtD
Cyclobenzaprine—Dermatitis—Erlotinib—pancreatic cancer	8.16e-05	0.00166	CcSEcCtD
Cyclobenzaprine—Insomnia—Gemcitabine—pancreatic cancer	8.14e-05	0.00166	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Irinotecan—pancreatic cancer	8.13e-05	0.00166	CcSEcCtD
Cyclobenzaprine—Headache—Erlotinib—pancreatic cancer	8.12e-05	0.00166	CcSEcCtD
Cyclobenzaprine—Diplopia—Doxorubicin—pancreatic cancer	8.11e-05	0.00165	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Doxorubicin—pancreatic cancer	8.11e-05	0.00165	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Gemcitabine—pancreatic cancer	8.08e-05	0.00165	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	8.06e-05	0.00164	CcSEcCtD
Cyclobenzaprine—Asthenia—Sunitinib—pancreatic cancer	8.05e-05	0.00164	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Irinotecan—pancreatic cancer	8.03e-05	0.00164	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Docetaxel—pancreatic cancer	8.03e-05	0.00164	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Gemcitabine—pancreatic cancer	8.02e-05	0.00164	CcSEcCtD
Cyclobenzaprine—Insomnia—Fluorouracil—pancreatic cancer	8e-05	0.00163	CcSEcCtD
Cyclobenzaprine—Somnolence—Gemcitabine—pancreatic cancer	8e-05	0.00163	CcSEcCtD
Cyclobenzaprine—Fatigue—Irinotecan—pancreatic cancer	7.97e-05	0.00162	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Fluorouracil—pancreatic cancer	7.95e-05	0.00162	CcSEcCtD
Cyclobenzaprine—Alopecia—Docetaxel—pancreatic cancer	7.94e-05	0.00162	CcSEcCtD
Cyclobenzaprine—Pruritus—Sunitinib—pancreatic cancer	7.94e-05	0.00162	CcSEcCtD
Cyclobenzaprine—Constipation—Irinotecan—pancreatic cancer	7.9e-05	0.00161	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Fluorouracil—pancreatic cancer	7.89e-05	0.00161	CcSEcCtD
Cyclobenzaprine—Somnolence—Fluorouracil—pancreatic cancer	7.87e-05	0.0016	CcSEcCtD
Cyclobenzaprine—Face oedema—Doxorubicin—pancreatic cancer	7.83e-05	0.0016	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Gemcitabine—pancreatic cancer	7.82e-05	0.0016	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Fluorouracil—pancreatic cancer	7.79e-05	0.00159	CcSEcCtD
Cyclobenzaprine—Nausea—Tamoxifen—pancreatic cancer	7.78e-05	0.00159	CcSEcCtD
Cyclobenzaprine—Fatigue—Gemcitabine—pancreatic cancer	7.76e-05	0.00158	CcSEcCtD
Cyclobenzaprine—Gastritis—Epirubicin—pancreatic cancer	7.76e-05	0.00158	CcSEcCtD
Cyclobenzaprine—Constipation—Gemcitabine—pancreatic cancer	7.7e-05	0.00157	CcSEcCtD
Cyclobenzaprine—Nausea—Erlotinib—pancreatic cancer	7.7e-05	0.00157	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Fluorouracil—pancreatic cancer	7.69e-05	0.00157	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Sunitinib—pancreatic cancer	7.68e-05	0.00157	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Docetaxel—pancreatic cancer	7.66e-05	0.00156	CcSEcCtD
Cyclobenzaprine—Ataxia—Doxorubicin—pancreatic cancer	7.63e-05	0.00156	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Irinotecan—pancreatic cancer	7.61e-05	0.00155	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Irinotecan—pancreatic cancer	7.56e-05	0.00154	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Epirubicin—pancreatic cancer	7.5e-05	0.00153	CcSEcCtD
Cyclobenzaprine—Dizziness—Sunitinib—pancreatic cancer	7.42e-05	0.00151	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Gemcitabine—pancreatic cancer	7.42e-05	0.00151	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Irinotecan—pancreatic cancer	7.3e-05	0.00149	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Fluorouracil—pancreatic cancer	7.29e-05	0.00149	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Epirubicin—pancreatic cancer	7.2e-05	0.00147	CcSEcCtD
Cyclobenzaprine—Gastritis—Doxorubicin—pancreatic cancer	7.18e-05	0.00146	CcSEcCtD
Cyclobenzaprine—Vomiting—Sunitinib—pancreatic cancer	7.13e-05	0.00145	CcSEcCtD
Cyclobenzaprine—Rash—Sunitinib—pancreatic cancer	7.07e-05	0.00144	CcSEcCtD
Cyclobenzaprine—Dermatitis—Sunitinib—pancreatic cancer	7.07e-05	0.00144	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	7.04e-05	0.00144	CcSEcCtD
Cyclobenzaprine—Urticaria—Fluorouracil—pancreatic cancer	7.03e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Headache—Sunitinib—pancreatic cancer	7.03e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Syncope—Docetaxel—pancreatic cancer	7.02e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Leukopenia—Docetaxel—pancreatic cancer	7.01e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Epirubicin—pancreatic cancer	7e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Doxorubicin—pancreatic cancer	6.94e-05	0.00142	CcSEcCtD
Cyclobenzaprine—Palpitations—Docetaxel—pancreatic cancer	6.92e-05	0.00141	CcSEcCtD
Cyclobenzaprine—Weight increased—Epirubicin—pancreatic cancer	6.9e-05	0.00141	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Docetaxel—pancreatic cancer	6.88e-05	0.0014	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Irinotecan—pancreatic cancer	6.81e-05	0.00139	CcSEcCtD
Cyclobenzaprine—Convulsion—Docetaxel—pancreatic cancer	6.78e-05	0.00138	CcSEcCtD
Cyclobenzaprine—Hypertension—Docetaxel—pancreatic cancer	6.76e-05	0.00138	CcSEcCtD
Cyclobenzaprine—Drowsiness—Epirubicin—pancreatic cancer	6.76e-05	0.00138	CcSEcCtD
Cyclobenzaprine—Chest pain—Docetaxel—pancreatic cancer	6.66e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Myalgia—Docetaxel—pancreatic cancer	6.66e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Nausea—Sunitinib—pancreatic cancer	6.66e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Doxorubicin—pancreatic cancer	6.66e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Asthenia—Irinotecan—pancreatic cancer	6.63e-05	0.00135	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Epirubicin—pancreatic cancer	6.62e-05	0.00135	CcSEcCtD
Cyclobenzaprine—Stomatitis—Epirubicin—pancreatic cancer	6.58e-05	0.00134	CcSEcCtD
Cyclobenzaprine—Jaundice—Epirubicin—pancreatic cancer	6.58e-05	0.00134	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Fluorouracil—pancreatic cancer	6.52e-05	0.00133	CcSEcCtD
Cyclobenzaprine—Dry mouth—Docetaxel—pancreatic cancer	6.52e-05	0.00133	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	6.52e-05	0.00133	CcSEcCtD
Cyclobenzaprine—Sweating—Epirubicin—pancreatic cancer	6.48e-05	0.00132	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—pancreatic cancer	6.48e-05	0.00132	CcSEcCtD
Cyclobenzaprine—Asthenia—Gemcitabine—pancreatic cancer	6.46e-05	0.00132	CcSEcCtD
Cyclobenzaprine—Confusional state—Docetaxel—pancreatic cancer	6.44e-05	0.00131	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Docetaxel—pancreatic cancer	6.39e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Oedema—Docetaxel—pancreatic cancer	6.39e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—pancreatic cancer	6.38e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Pruritus—Gemcitabine—pancreatic cancer	6.37e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Irinotecan—pancreatic cancer	6.32e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Epirubicin—pancreatic cancer	6.3e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Shock—Docetaxel—pancreatic cancer	6.28e-05	0.00128	CcSEcCtD
Cyclobenzaprine—Pruritus—Fluorouracil—pancreatic cancer	6.26e-05	0.00128	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Docetaxel—pancreatic cancer	6.25e-05	0.00128	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—pancreatic cancer	6.25e-05	0.00127	CcSEcCtD
Cyclobenzaprine—Tachycardia—Docetaxel—pancreatic cancer	6.23e-05	0.00127	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Gemcitabine—pancreatic cancer	6.16e-05	0.00126	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	6.13e-05	0.00125	CcSEcCtD
Cyclobenzaprine—Dizziness—Irinotecan—pancreatic cancer	6.11e-05	0.00125	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—pancreatic cancer	6.09e-05	0.00124	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—pancreatic cancer	6.09e-05	0.00124	CcSEcCtD
Cyclobenzaprine—Anorexia—Docetaxel—pancreatic cancer	6.09e-05	0.00124	CcSEcCtD
Cyclobenzaprine—Hepatitis—Epirubicin—pancreatic cancer	6.06e-05	0.00124	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Fluorouracil—pancreatic cancer	6.06e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Epirubicin—pancreatic cancer	6.03e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Epirubicin—pancreatic cancer	6.02e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—pancreatic cancer	5.99e-05	0.00122	CcSEcCtD
Cyclobenzaprine—Hypotension—Docetaxel—pancreatic cancer	5.97e-05	0.00122	CcSEcCtD
Cyclobenzaprine—Vomiting—Irinotecan—pancreatic cancer	5.88e-05	0.0012	CcSEcCtD
Cyclobenzaprine—Dizziness—Fluorouracil—pancreatic cancer	5.85e-05	0.00119	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—pancreatic cancer	5.83e-05	0.00119	CcSEcCtD
Cyclobenzaprine—Rash—Irinotecan—pancreatic cancer	5.83e-05	0.00119	CcSEcCtD
Cyclobenzaprine—Dermatitis—Irinotecan—pancreatic cancer	5.82e-05	0.00119	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	5.82e-05	0.00119	CcSEcCtD
Cyclobenzaprine—Headache—Irinotecan—pancreatic cancer	5.79e-05	0.00118	CcSEcCtD
Cyclobenzaprine—Insomnia—Docetaxel—pancreatic cancer	5.78e-05	0.00118	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Docetaxel—pancreatic cancer	5.74e-05	0.00117	CcSEcCtD
Cyclobenzaprine—Vomiting—Gemcitabine—pancreatic cancer	5.72e-05	0.00117	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Docetaxel—pancreatic cancer	5.69e-05	0.00116	CcSEcCtD
Cyclobenzaprine—Somnolence—Docetaxel—pancreatic cancer	5.68e-05	0.00116	CcSEcCtD
Cyclobenzaprine—Rash—Gemcitabine—pancreatic cancer	5.68e-05	0.00116	CcSEcCtD
Cyclobenzaprine—Dermatitis—Gemcitabine—pancreatic cancer	5.67e-05	0.00116	CcSEcCtD
Cyclobenzaprine—Tinnitus—Epirubicin—pancreatic cancer	5.65e-05	0.00115	CcSEcCtD
Cyclobenzaprine—Headache—Gemcitabine—pancreatic cancer	5.64e-05	0.00115	CcSEcCtD
Cyclobenzaprine—Vomiting—Fluorouracil—pancreatic cancer	5.63e-05	0.00115	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Docetaxel—pancreatic cancer	5.62e-05	0.00115	CcSEcCtD
Cyclobenzaprine—Hepatitis—Doxorubicin—pancreatic cancer	5.61e-05	0.00114	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—pancreatic cancer	5.58e-05	0.00114	CcSEcCtD
Cyclobenzaprine—Rash—Fluorouracil—pancreatic cancer	5.58e-05	0.00114	CcSEcCtD
Cyclobenzaprine—Dermatitis—Fluorouracil—pancreatic cancer	5.57e-05	0.00114	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—pancreatic cancer	5.57e-05	0.00114	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Docetaxel—pancreatic cancer	5.55e-05	0.00113	CcSEcCtD
Cyclobenzaprine—Headache—Fluorouracil—pancreatic cancer	5.54e-05	0.00113	CcSEcCtD
Cyclobenzaprine—Fatigue—Docetaxel—pancreatic cancer	5.51e-05	0.00112	CcSEcCtD
Cyclobenzaprine—Nausea—Irinotecan—pancreatic cancer	5.49e-05	0.00112	CcSEcCtD
Cyclobenzaprine—Constipation—Docetaxel—pancreatic cancer	5.46e-05	0.00111	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Epirubicin—pancreatic cancer	5.42e-05	0.0011	CcSEcCtD
Cyclobenzaprine—Alopecia—Epirubicin—pancreatic cancer	5.36e-05	0.00109	CcSEcCtD
Cyclobenzaprine—Nausea—Gemcitabine—pancreatic cancer	5.35e-05	0.00109	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Docetaxel—pancreatic cancer	5.26e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Nausea—Fluorouracil—pancreatic cancer	5.26e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—pancreatic cancer	5.23e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Docetaxel—pancreatic cancer	5.22e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Flatulence—Epirubicin—pancreatic cancer	5.2e-05	0.00106	CcSEcCtD
Cyclobenzaprine—Tension—Epirubicin—pancreatic cancer	5.18e-05	0.00106	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Epirubicin—pancreatic cancer	5.17e-05	0.00105	CcSEcCtD
Cyclobenzaprine—Nervousness—Epirubicin—pancreatic cancer	5.13e-05	0.00105	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Docetaxel—pancreatic cancer	5.05e-05	0.00103	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—pancreatic cancer	5.01e-05	0.00102	CcSEcCtD
Cyclobenzaprine—Vision blurred—Epirubicin—pancreatic cancer	4.98e-05	0.00101	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—pancreatic cancer	4.96e-05	0.00101	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Epirubicin—pancreatic cancer	4.9e-05	0.000999	CcSEcCtD
Cyclobenzaprine—Agitation—Epirubicin—pancreatic cancer	4.85e-05	0.000989	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—pancreatic cancer	4.81e-05	0.000982	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—pancreatic cancer	4.79e-05	0.000977	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—pancreatic cancer	4.78e-05	0.000975	CcSEcCtD
Cyclobenzaprine—Malaise—Epirubicin—pancreatic cancer	4.76e-05	0.000971	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—pancreatic cancer	4.74e-05	0.000967	CcSEcCtD
Cyclobenzaprine—Vertigo—Epirubicin—pancreatic cancer	4.74e-05	0.000967	CcSEcCtD
Cyclobenzaprine—Syncope—Epirubicin—pancreatic cancer	4.73e-05	0.000965	CcSEcCtD
Cyclobenzaprine—Leukopenia—Epirubicin—pancreatic cancer	4.73e-05	0.000964	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Docetaxel—pancreatic cancer	4.71e-05	0.00096	CcSEcCtD
Cyclobenzaprine—Palpitations—Epirubicin—pancreatic cancer	4.67e-05	0.000951	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Epirubicin—pancreatic cancer	4.64e-05	0.000946	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—pancreatic cancer	4.6e-05	0.000939	CcSEcCtD
Cyclobenzaprine—Asthenia—Docetaxel—pancreatic cancer	4.58e-05	0.000935	CcSEcCtD
Cyclobenzaprine—Convulsion—Epirubicin—pancreatic cancer	4.57e-05	0.000933	CcSEcCtD
Cyclobenzaprine—Hypertension—Epirubicin—pancreatic cancer	4.56e-05	0.000929	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.53e-05	0.000924	CcSEcCtD
Cyclobenzaprine—Pruritus—Docetaxel—pancreatic cancer	4.52e-05	0.000922	CcSEcCtD
Cyclobenzaprine—Myalgia—Epirubicin—pancreatic cancer	4.49e-05	0.000916	CcSEcCtD
Cyclobenzaprine—Chest pain—Epirubicin—pancreatic cancer	4.49e-05	0.000916	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—pancreatic cancer	4.49e-05	0.000915	CcSEcCtD
Cyclobenzaprine—Anxiety—Epirubicin—pancreatic cancer	4.48e-05	0.000913	CcSEcCtD
Cyclobenzaprine—Discomfort—Epirubicin—pancreatic cancer	4.44e-05	0.000906	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—pancreatic cancer	4.4e-05	0.000898	CcSEcCtD
Cyclobenzaprine—Dry mouth—Epirubicin—pancreatic cancer	4.4e-05	0.000896	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—pancreatic cancer	4.39e-05	0.000895	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—pancreatic cancer	4.38e-05	0.000893	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—pancreatic cancer	4.37e-05	0.000892	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Docetaxel—pancreatic cancer	4.37e-05	0.000891	CcSEcCtD
Cyclobenzaprine—Confusional state—Epirubicin—pancreatic cancer	4.34e-05	0.000886	CcSEcCtD
Cyclobenzaprine—Palpitations—Doxorubicin—pancreatic cancer	4.32e-05	0.00088	CcSEcCtD
Cyclobenzaprine—Oedema—Epirubicin—pancreatic cancer	4.31e-05	0.000879	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Epirubicin—pancreatic cancer	4.31e-05	0.000879	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—pancreatic cancer	4.29e-05	0.000875	CcSEcCtD
Cyclobenzaprine—Shock—Epirubicin—pancreatic cancer	4.24e-05	0.000864	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—pancreatic cancer	4.23e-05	0.000863	CcSEcCtD
Cyclobenzaprine—Dizziness—Docetaxel—pancreatic cancer	4.22e-05	0.000861	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Epirubicin—pancreatic cancer	4.22e-05	0.00086	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—pancreatic cancer	4.22e-05	0.00086	CcSEcCtD
Cyclobenzaprine—Tachycardia—Epirubicin—pancreatic cancer	4.2e-05	0.000857	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Epirubicin—pancreatic cancer	4.17e-05	0.000849	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—pancreatic cancer	4.16e-05	0.000848	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—pancreatic cancer	4.16e-05	0.000848	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—pancreatic cancer	4.14e-05	0.000845	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—pancreatic cancer	4.11e-05	0.000838	CcSEcCtD
Cyclobenzaprine—Anorexia—Epirubicin—pancreatic cancer	4.11e-05	0.000837	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—pancreatic cancer	4.07e-05	0.000829	CcSEcCtD
Cyclobenzaprine—Vomiting—Docetaxel—pancreatic cancer	4.06e-05	0.000828	CcSEcCtD
Cyclobenzaprine—Rash—Docetaxel—pancreatic cancer	4.03e-05	0.000821	CcSEcCtD
Cyclobenzaprine—Hypotension—Epirubicin—pancreatic cancer	4.03e-05	0.000821	CcSEcCtD
Cyclobenzaprine—Dermatitis—Docetaxel—pancreatic cancer	4.02e-05	0.000821	CcSEcCtD
Cyclobenzaprine—Confusional state—Doxorubicin—pancreatic cancer	4.02e-05	0.00082	CcSEcCtD
Cyclobenzaprine—Headache—Docetaxel—pancreatic cancer	4e-05	0.000816	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—pancreatic cancer	3.99e-05	0.000813	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—pancreatic cancer	3.99e-05	0.000813	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.93e-05	0.0008	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—pancreatic cancer	3.92e-05	0.0008	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.9e-05	0.000796	CcSEcCtD
Cyclobenzaprine—Insomnia—Epirubicin—pancreatic cancer	3.9e-05	0.000795	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—pancreatic cancer	3.89e-05	0.000793	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Epirubicin—pancreatic cancer	3.87e-05	0.000789	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—pancreatic cancer	3.85e-05	0.000786	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Epirubicin—pancreatic cancer	3.84e-05	0.000783	CcSEcCtD
Cyclobenzaprine—Somnolence—Epirubicin—pancreatic cancer	3.83e-05	0.000781	CcSEcCtD
Cyclobenzaprine—Anorexia—Doxorubicin—pancreatic cancer	3.8e-05	0.000775	CcSEcCtD
Cyclobenzaprine—Nausea—Docetaxel—pancreatic cancer	3.79e-05	0.000774	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Epirubicin—pancreatic cancer	3.79e-05	0.000773	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Epirubicin—pancreatic cancer	3.75e-05	0.000764	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—pancreatic cancer	3.73e-05	0.00076	CcSEcCtD
Cyclobenzaprine—Fatigue—Epirubicin—pancreatic cancer	3.71e-05	0.000757	CcSEcCtD
Cyclobenzaprine—Constipation—Epirubicin—pancreatic cancer	3.68e-05	0.000751	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.63e-05	0.000741	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—pancreatic cancer	3.61e-05	0.000735	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Doxorubicin—pancreatic cancer	3.58e-05	0.00073	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—pancreatic cancer	3.55e-05	0.000725	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Epirubicin—pancreatic cancer	3.55e-05	0.000724	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—pancreatic cancer	3.54e-05	0.000723	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.52e-05	0.000718	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—pancreatic cancer	3.51e-05	0.000716	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—pancreatic cancer	3.47e-05	0.000707	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—pancreatic cancer	3.44e-05	0.000701	CcSEcCtD
Cyclobenzaprine—Urticaria—Epirubicin—pancreatic cancer	3.42e-05	0.000698	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—pancreatic cancer	3.41e-05	0.000695	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Epirubicin—pancreatic cancer	3.41e-05	0.000695	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—pancreatic cancer	3.29e-05	0.00067	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.26e-05	0.000665	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Epirubicin—pancreatic cancer	3.17e-05	0.000647	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—pancreatic cancer	3.17e-05	0.000646	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—pancreatic cancer	3.15e-05	0.000643	CcSEcCtD
Cyclobenzaprine—Asthenia—Epirubicin—pancreatic cancer	3.09e-05	0.00063	CcSEcCtD
Cyclobenzaprine—Pruritus—Epirubicin—pancreatic cancer	3.05e-05	0.000622	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Epirubicin—pancreatic cancer	2.95e-05	0.000601	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—pancreatic cancer	2.94e-05	0.000599	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—pancreatic cancer	2.86e-05	0.000583	CcSEcCtD
Cyclobenzaprine—Dizziness—Epirubicin—pancreatic cancer	2.85e-05	0.000581	CcSEcCtD
Cyclobenzaprine—Pruritus—Doxorubicin—pancreatic cancer	2.82e-05	0.000575	CcSEcCtD
Cyclobenzaprine—Vomiting—Epirubicin—pancreatic cancer	2.74e-05	0.000559	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—pancreatic cancer	2.73e-05	0.000556	CcSEcCtD
Cyclobenzaprine—Rash—Epirubicin—pancreatic cancer	2.72e-05	0.000554	CcSEcCtD
Cyclobenzaprine—Dermatitis—Epirubicin—pancreatic cancer	2.71e-05	0.000553	CcSEcCtD
Cyclobenzaprine—Headache—Epirubicin—pancreatic cancer	2.7e-05	0.00055	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—pancreatic cancer	2.64e-05	0.000538	CcSEcCtD
Cyclobenzaprine—Nausea—Epirubicin—pancreatic cancer	2.56e-05	0.000522	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—pancreatic cancer	2.53e-05	0.000517	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—pancreatic cancer	2.51e-05	0.000513	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—pancreatic cancer	2.51e-05	0.000512	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—pancreatic cancer	2.5e-05	0.000509	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—pancreatic cancer	2.37e-05	0.000483	CcSEcCtD
